These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8463770)

  • 21. Toxoplasmosis in AIDS: keeping the lid on.
    Kovacs JA
    Ann Intern Med; 1995 Aug; 123(3):230-1. PubMed ID: 7598306
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute renal failure caused by sulfadiazine crystalluria in AIDS. An historical resurgent iatrogenic complication].
    De Jaureguiberry JP; Reboul P; Vey N; Jaubert D
    Ann Med Interne (Paris); 1992; 143(3):218-9. PubMed ID: 1524357
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulfonamide crystals and acute renal failure.
    Swaminathan S; Pollett S; Loblay R; Macleod C
    Intern Med J; 2006 Jun; 36(6):399-400. PubMed ID: 16732870
    [No Abstract]   [Full Text] [Related]  

  • 24. Resolution of acute renal failure in toxoplasmic encephalitis despite continuance of sulfadiazine.
    Oster S; Hutchison F; McCabe R
    Rev Infect Dis; 1990; 12(4):618-20. PubMed ID: 2385768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
    Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J
    AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
    Arens J; Barnes K; Crowley N; Maartens G
    S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfadiazine-induced nephrolithiasis detected by spiral CT scan.
    Lee SA; James CW; Szabo S; Dressler RM
    Del Med J; 2004 Feb; 76(2):59-63. PubMed ID: 15025231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstructive nephropathy due to sulfa crystals in two HIV seropositive patients treated with sulfadiazine.
    Colebunders R; Depraetere K; De Droogh E; Kamper A; Corthout B; Bottiau E
    JBR-BTR; 1999 Aug; 82(4):153-4. PubMed ID: 10555419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral toxoplasmosis and AIDS. Clinical, neuroradiological and immunological findings in 15 patients.
    Orefice G; Carrieri PB; Chirianni A; Rubino S; Liuzzi G; Napolitano G; Rocco A
    Acta Neurol (Napoli); 1992; 14(4-6):493-502. PubMed ID: 1293991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Winstanley P
    Postgrad Med J; 1995 Jul; 71(837):404-8. PubMed ID: 7567731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute encephalopathy caused by sulfadiazine and trimethoprim-sulfamethoxazole in a patient with AIDS].
    Arjol AM; Sánchez C; Dalmau D
    Enferm Infecc Microbiol Clin; 1998 May; 16(5):250-1. PubMed ID: 9666594
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
    Simon DI; Brosius FC; Rothstein DM
    Arch Intern Med; 1990 Nov; 150(11):2379-84. PubMed ID: 2241449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empiric treatment of acute Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
    Iribarren JA; Arrizabalaga J; Garde C; Rodriguez-Arrondo F; Blanco A
    Arch Intern Med; 1992 Oct; 152(10):2139-40. PubMed ID: 1417389
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
    Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
    Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Movement disorders with cerebral toxoplasmosis and AIDS.
    Nath A; Hobson DE; Russell A
    Mov Disord; 1993; 8(1):107-12. PubMed ID: 8419793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic approaches for AIDS-related toxoplasmosis.
    Behbahani R; Moshfeghi M; Baxter JD
    Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A solitary brain lesion in a patient with AIDS.
    Ball SC
    AIDS Read; 2003 Jan; 13(1):11-4. PubMed ID: 12569890
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome.
    Carbone LG; Bendixen B; Appel GB
    Am J Kidney Dis; 1988 Jul; 12(1):72-5. PubMed ID: 3389358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.